Product
BA3071
1 clinical trial
11 indications
Indication
Solid TumorIndication
AdultIndication
NSCLCIndication
Bladder CancerIndication
Stomach CancerIndication
Small Cell Lung CancerIndication
Hepatocellular CarcinomaIndication
Cervical CancerIndication
MelanomaIndication
Renal Cell CarcinomaIndication
cancerClinical trial
A Phase 1/2 Study of BA3071 as Monotherapy and in Combination With a PD-1 Blocking Antibody in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-30